术期间使用C1-雌激酶抑制剂治疗,使高度敏感的肺移植候选人能够进行移植:三个病例报告
Jérôme Devaquet1, Benjamin Coiffard2, Xavier Demant3
1Department of Intensive Care Medicine, Foch Hospital, Suresnes, France.
概括
在高度敏感的肺移植候选人中使用C1-雌激酶抑制剂改善了结果. 这种方法促进了成功的双边肺移植,克服了移植功能障碍和排斥的风险.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 高度敏感的肺移植候选人面临着移植分配和死亡风险增加的挑战.
- 通过经典和莱克通路的补充激活有助于抗体介导的排斥.
- C1-雌激酶抑制剂是预防和治疗脏和心脏移植中排斥的已知治疗药物.
研究的目的:
- 评估C1-酶抑制剂在高度敏感的肺移植候选人的术后使用.
- 评估C1-雌激酶抑制剂在肺移植期间预防严重的移植并发症的疗效.
主要方法:
- 三位高度敏感的肺移植接受者的回顾性病例系列.
- 在外科手术期间使用C1-雌激酶抑制剂.
- 监测原发性移植功能障碍和抗体介导排斥.
主要成果:
- 在这三个案例中,双边肺移植成功.
- 尽管严重的初级移植功能障碍和/或过敏的抗体中介排斥,患者取得了成功的移植结果.
- 在外科手术期间使用C1-雌激酶抑制剂与移植结果呈阳性相关.
结论:
- 对于高度敏感的肺移植候选人来说,C1-雌激酶抑制剂可能是一个有价值的治疗选择.
- 在外科手术期间使用C1-雌激酶抑制剂可以减轻与严重的初级移植功能障碍和抗体中介排斥相关的风险.
- 需要进一步的研究,以确定C1-雌激酶抑制剂作为这种患者群体的标准治疗.
更多相关视频
07:28Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
302
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
144
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
144
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
127
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
127